Carregant...
The Expanding Use of Third-Generation Aromatase Inhibitors: What the General Internist Needs to Know
BACKGROUND: Breast cancer patients represent the largest group of adult cancer survivors in the US. Most breast cancers in women 50 years of age and older are hormone receptor positive. Third generation aromatase inhibitors (AIs) are the newest class of drugs used in treating hormone responsive brea...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer-Verlag
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2763159/ https://ncbi.nlm.nih.gov/pubmed/19838836 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11606-009-1037-2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|